abacavir

(redirected from Abacavir sulfate)
Also found in: Medical.

a·bac·a·vir

 (ə-băk′ə-vîr′)
n.
An antiviral drug, C14H18N6O, that is a nucleoside reverse transcriptor inhibitor and is used in its sulfate form in combination with other drugs for the treatment of HIV infection.

[aba- (perhaps from ab, first two letters of the alphabet, from the fact that it was the first of this type of antiviral developed) + -c(arbocyclic nucleoside), nucleoside whose oxygen in the sugar ring has been replaced by a carbon + a(nti)vir(al) .]
Translations

abacavir

n abacavir m
References in periodicals archive ?
Abacavir sulfate and lamivudine tablets in 600 mg and 300 mg doses is a generic bioequivalent of VIV Healthcare's Epzicom tablets, used to treat HIV-1 infection, while olmesartan medoxomil and hydrochlorothiazide tablets, 20 mg/12.5 mg, 40 mg/12.5 mg and 40 mg/25 mg, have been judged therapeutically equivalent to Daiichi Sankyo Ltd.'s Benicar HCT, which is used to treat hypertension.
M2 EQUITYBITES-March 30, 2017-Aurobindo Pharma gains US FDA approval to manufacture abacavir sulfate and lamivudine tablets
M2 PHARMA-March 30, 2017-Aurobindo Pharma gains US FDA approval to manufacture abacavir sulfate and lamivudine tablets
From Abacavir sulfate to Zonisamide, this updated guide includes monographs on some 4,700 prescription, over-the-counter, and investigational drugs.
For example, abacavir sulfate (Ziagen) received regulatory approval when research showed that it lowered viral load.
has launched abacavir sulfate, lamivudine and zidovudine tablets, 300 mg (base)/150 mg/300 mg in the United States after a federal district court ruled that its generic version of Trizivir did not infringe on patents.
M2 PHARMA-February 24, 2012-Mylan Inc awarded tentative FDA approval for Abacavir Sulfate and Lamivudine Tablets for pediatric HIV/AIDS(C)2012 M2 COMMUNICATIONS
Drug supply PNSP 2014-1-083: Abacavir sulfate and lamivudine.